Sidhu P, Sutherland S B, Ganguly P
Am J Physiol. 1979 Sep;237(3):H353-8. doi: 10.1152/ajpheart.1979.237.3.H353.
In this study we have explored the interaction of thrombin with platelets from human and rat. Compared to human platelets, rat platelets suspended in plasma required a higher concentration of thrombin for aggregation. This difference in sensitivity to thrombin was maintained when platelets were washed and suspended in buffer. Platelets from both mammals bound thrombin and showed a similar number of binding sites. However, the apparent dissociation constant of thrombin binding for rat platelets was approximately 15-fold higher than that for human. Thus, the decreased aggregation response of rat platelets may be due to a reduced binding of thrombin to its receptor. It is known that the thrombin receptor is located on the platelet surface. Gel electrophoresis of platelets followed by specific staining as well as fluorography showed significant differences in the surface glycoproteins of human and rat platelets. Human platelets showed labeled components corresponding to 210,000 and 160,000 daltons, whereas rat platelets showed glycoproteins with molecular weights of 240,000 and 190,000. A 135,000-dalton component was present in platelets from both sources. These results suggest that either or both glycoproteins of 210,000 and 160,000 daltons may be involved in the interaction of thrombin with human platelets.
在本研究中,我们探讨了凝血酶与人和大鼠血小板的相互作用。与人类血小板相比,悬浮于血浆中的大鼠血小板聚集需要更高浓度的凝血酶。当血小板被洗涤并悬浮于缓冲液中时,这种对凝血酶敏感性的差异依然存在。两种哺乳动物的血小板均能结合凝血酶,且结合位点数量相似。然而,凝血酶与大鼠血小板结合的表观解离常数比与人类血小板结合的表观解离常数高约15倍。因此,大鼠血小板聚集反应降低可能是由于凝血酶与其受体的结合减少所致。已知凝血酶受体位于血小板表面。对血小板进行凝胶电泳,随后进行特异性染色以及荧光自显影,结果显示人和大鼠血小板的表面糖蛋白存在显著差异。人类血小板显示出对应于210,000和160,000道尔顿的标记成分,而大鼠血小板显示出分子量为240,000和190,000的糖蛋白。两种来源的血小板中均存在一种135,000道尔顿的成分。这些结果表明,210,000和160,000道尔顿的糖蛋白中的一种或两种可能参与了凝血酶与人类血小板的相互作用。